Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-052146

Chief Executive Officer gave up 79,328 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-09-22 Shares withheld for taxes −79,328 $39.85 $3,161,221 733,285 D
Loading xslF345X03/doc4.xml…